XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Cash, cash equivalents and short term investments | 38.19%2.48B | 38.19%2.48B | 2.20%2.51B | 2.74%2.51B | -6.22%2.28B | -25.90%1.79B | -25.90%1.79B | -22.19%2.45B | -28.70%2.44B | -15.95%2.43B |
-Cash and cash equivalents | 327.40%1.2B | 327.40%1.2B | 56.88%1.02B | 108.02%1.12B | 71.51%885M | -16.86%281M | -16.86%281M | -5.96%647M | -31.11%536M | -17.83%516M |
-Short-term investments | -15.63%1.27B | -15.63%1.27B | -17.41%1.49B | -26.86%1.39B | -27.18%1.39B | -27.37%1.51B | -27.37%1.51B | -26.73%1.8B | -27.99%1.91B | -15.43%1.91B |
Receivables | 45.69%558M | 45.69%558M | 49.56%510M | 5.41%370M | 12.94%384M | 29.39%383M | 29.39%383M | -1.16%341M | -12.47%351M | -48.33%340M |
-Accounts receivable | 45.69%558M | 45.69%558M | 49.56%510M | 5.41%370M | 12.94%384M | 29.39%383M | 29.39%383M | -1.16%341M | -12.47%351M | -48.33%340M |
Inventory | 71.55%199M | 71.55%199M | 65.57%202M | -0.93%106M | -0.95%104M | 11.54%116M | 11.54%116M | 29.79%122M | 15.05%107M | 34.62%105M |
Prepaid assets | 74.43%307M | 74.43%307M | 44.39%270M | -4.28%179M | -2.21%177M | 7.98%176M | 7.98%176M | -15.38%187M | -40.26%187M | -47.99%181M |
Restricted cash | --29M | --29M | --27M | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Other current assets | -19.67%192M | -19.67%192M | 41.14%223M | 35.03%212M | 322.73%186M | 298.33%239M | 298.33%239M | --158M | --157M | --44M |
Total current assets | 39.00%3.76B | 39.00%3.76B | 2.55%3.74B | 4.07%3.38B | 0.97%3.13B | -11.02%2.71B | -11.02%2.71B | -4.36%3.64B | -23.35%3.24B | -22.02%3.1B |
Non current assets | ||||||||||
Net PPE | 26.03%12.08B | 26.03%12.08B | 29.04%11.87B | 4.12%9.66B | 6.62%9.37B | 9.80%9.58B | 9.80%9.58B | 11.36%9.2B | 14.02%9.28B | 12.89%8.79B |
-Gross PPE | 19.39%16.63B | 19.39%16.63B | 21.78%16.42B | 5.19%14.2B | 6.50%13.81B | 8.32%13.93B | 8.32%13.93B | 9.55%13.48B | 11.92%13.5B | 11.79%12.96B |
-Accumulated depreciation | -4.74%-4.55B | -4.74%-4.55B | -6.19%-4.55B | -7.54%-4.54B | -6.25%-4.44B | -5.21%-4.34B | -5.21%-4.34B | -5.86%-4.28B | -7.57%-4.22B | -9.54%-4.18B |
Goodwill and other intangible assets | 76.93%3.6B | 76.93%3.6B | 76.55%3.59B | -0.15%2.03B | -0.20%2.03B | -0.25%2.03B | -0.25%2.03B | -0.29%2.03B | -0.24%2.04B | -0.24%2.04B |
-Goodwill | 40.20%2.72B | 40.20%2.72B | --2.7B | ---- | ---- | --1.94B | --1.94B | ---- | ---- | ---- |
-Other intangible assets | 870.00%873M | 870.00%873M | --888M | ---- | ---- | --90M | --90M | ---- | ---- | ---- |
Other non current assets | 14.38%334M | 14.38%334M | 25.17%363M | 0.75%270M | -24.33%283M | -23.16%292M | -23.16%292M | -31.28%290M | -30.75%268M | -9.00%374M |
Total non current assets | 34.43%16.01B | 34.43%16.01B | 37.33%15.82B | 3.29%11.97B | 4.35%11.68B | 6.84%11.91B | 6.84%11.91B | 7.46%11.52B | 9.62%11.59B | 9.39%11.2B |
Total assets | 35.28%19.77B | 35.28%19.77B | 28.97%19.56B | 3.46%15.34B | 3.62%14.81B | 3.01%14.61B | 3.01%14.61B | 4.36%15.17B | 0.20%14.83B | 0.61%14.3B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Payables | -10.14%186M | -10.14%186M | 5.68%242M | -4.25%203M | -12.14%181M | -6.33%207M | -6.33%207M | 13.37%229M | -25.87%212M | -31.10%206M |
-accounts payable | -10.14%186M | -10.14%186M | 5.68%242M | -4.25%203M | -12.14%181M | -6.33%207M | -6.33%207M | 13.37%229M | -25.87%212M | -31.10%206M |
Current accrued expenses | 44.36%2B | 44.36%2B | 30.21%1.78B | 2.32%1.37B | -5.00%1.27B | -5.53%1.38B | -5.53%1.38B | -1.51%1.37B | 10.25%1.33B | 30.51%1.34B |
Current debt and capital lease obligation | 28.57%657M | 28.57%657M | -17.16%734M | -39.69%512M | -4.57%459M | 1.39%511M | 1.39%511M | 51.71%886M | 37.82%849M | -14.72%481M |
-Current debt | 52.94%442M | 52.94%442M | -28.94%523M | -37.24%359M | 12.31%301M | 4.71%289M | 4.71%289M | 129.28%736M | 67.25%572M | -8.22%268M |
-Current capital lease obligation | -3.15%215M | -3.15%215M | 40.67%211M | -44.77%153M | -25.82%158M | -2.63%222M | -2.63%222M | -42.97%150M | 1.09%277M | -21.69%213M |
Current deferred liabilities | 40.18%3.3B | 40.18%3.3B | 34.72%3.49B | 3.85%2.89B | 3.04%2.92B | 2.34%2.36B | 2.34%2.36B | 2.25%2.59B | -0.32%2.78B | 5.59%2.83B |
Current liabilities | 37.81%6.15B | 37.81%6.15B | 23.14%6.25B | -4.02%4.97B | -0.58%4.83B | -0.76%4.46B | -0.76%4.46B | 7.75%5.07B | 5.59%5.18B | 6.28%4.86B |
Non current liabilities | ||||||||||
Long term debt and capital lease obligation | 73.45%5.74B | 73.45%5.74B | 66.86%5.41B | 10.73%3.36B | 3.45%3.36B | 0.95%3.31B | 0.95%3.31B | -3.86%3.24B | -12.38%3.04B | -5.39%3.25B |
-Long term debt | 105.82%4.49B | 105.82%4.49B | 95.44%4.16B | 22.45%2.31B | 26.13%2.26B | 15.88%2.18B | 15.88%2.18B | 12.65%2.13B | -3.67%1.89B | -13.62%1.8B |
-Long term capital lease obligation | 10.67%1.25B | 10.67%1.25B | 12.22%1.25B | -8.54%1.05B | -24.54%1.1B | -19.24%1.13B | -19.24%1.13B | -24.90%1.11B | -23.72%1.15B | 7.22%1.46B |
Non current deferred liabilities | 25.08%2.6B | 25.08%2.6B | 21.65%2.47B | 5.01%2.08B | 6.55%1.97B | 6.62%2.08B | 6.62%2.08B | 2.22%2.03B | -0.25%1.98B | -2.89%1.85B |
Employee benefits | 27.07%460M | 27.07%460M | 37.23%505M | -1.10%358M | 2.82%365M | 4.02%362M | 4.02%362M | 24.32%368M | 21.07%362M | 17.55%355M |
Other non current liabilities | 54.92%457M | 54.92%457M | 25.21%452M | 7.65%352M | 4.71%311M | -3.28%295M | -3.28%295M | 4.64%361M | -7.37%327M | -18.18%297M |
Total non current liabilities | 53.14%9.25B | 53.14%9.25B | 47.25%8.83B | 7.82%6.15B | 4.47%6.01B | 2.79%6.04B | 2.79%6.04B | 0.03%6B | -6.51%5.7B | -4.21%5.75B |
Total liabilities | 46.63%15.4B | 46.63%15.4B | 36.20%15.08B | 2.19%11.12B | 2.16%10.84B | 1.25%10.5B | 1.25%10.5B | 3.43%11.07B | -1.12%10.88B | 0.32%10.61B |
Shareholders'equity | ||||||||||
Share capital | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M |
-common stock | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M | 0.00%1M |
-Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Retained earnings | 8.71%4.93B | 8.71%4.93B | 7.10%4.86B | 5.12%4.62B | 5.89%4.4B | 5.47%4.54B | 5.47%4.54B | 6.05%4.54B | 3.78%4.4B | 1.44%4.16B |
Paid-in capital | 16.69%811M | 16.69%811M | 16.69%769M | 16.82%757M | 20.44%707M | 20.45%695M | 20.45%695M | 20.04%659M | 19.56%648M | 16.70%587M |
Less: Treasury stock | 38.10%1.13B | 38.10%1.13B | 18.55%882M | 18.74%868M | 21.39%840M | 21.51%819M | 21.51%819M | 10.39%744M | 8.46%731M | 2.67%692M |
Gains losses not affecting retained earnings | 20.07%-239M | 20.07%-239M | 25.56%-268M | 21.37%-287M | 19.45%-294M | 22.94%-299M | 22.94%-299M | -9.76%-360M | -18.51%-365M | -25.00%-365M |
Total stockholders'equity | 6.30%4.37B | 6.30%4.37B | 9.43%4.48B | 6.96%4.23B | 7.81%3.98B | 7.78%4.11B | 7.78%4.11B | 6.98%4.09B | 4.00%3.95B | 1.43%3.69B |
Total equity | 6.30%4.37B | 6.30%4.37B | 9.43%4.48B | 6.96%4.23B | 7.81%3.98B | 7.78%4.11B | 7.78%4.11B | 6.98%4.09B | 4.00%3.95B | 1.43%3.69B |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |